Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma

Glaucoma, a common cause of blindness, is currently treated by intraocular pressure (IOP)–lowering interventions. However, this approach is insufficient to completely prevent vision loss. Here, we evaluate an IOP-independent gene therapy strategy using a modified erythropoietin, EPO-R76E, which has...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther
Main Authors: Bond, Wesley S, Hines-Beard, Jessica, GoldenMerry, YPaul L, Davis, Mara, Farooque, Alma, Sappington, Rebecca M, Calkins, David J, Rex, Tonia S
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4817814/
https://ncbi.nlm.nih.gov/pubmed/26502777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2015.198
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados